Status:
COMPLETED
Cardiomyocyte Apoptosis Following Antegrade and Retrograde Cardioplegia
Lead Sponsor:
Turku University Hospital
Collaborating Sponsors:
Finnish Foundation for Cardiovascular Research
Conditions:
Cardiomyocyte Apoptosis
Eligibility:
All Genders
60-90 years
Brief Summary
Retrograde cardioplegia during heart surgery is associated with inadequate myocardial protection. In experimental animal study retrograde cardioplegia induces more cardiomyocyte apoptosis when compare...
Eligibility Criteria
Inclusion
- aortic valve stenosis or combined aortic valve disease
Exclusion
- angiographically verified hemodynamically significant coronary artery disease impaired left ventricular function (left ventricular ejection fraction \<50%) surgery including additional procedures other than aortic valve replacement cancer
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01185912
Start Date
January 1 2008
End Date
January 1 2010
Last Update
May 20 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turku University Hospital, Department of Surgery
Turku, Finland, 20521